Evidence map›Paper›PMID 40308419›Full record

ArticleCureus2025

Omega-5-Gliadin Allergy and Cofactors Leading to Anaphylaxis: A Case Report.

Beatrice Le Bon Chami, Fida Charif, Silvana El Zoghbi, Samir Challita, Fares Zaitoun

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Beatrice Le Bon ChamiPulmonology and Critical Care, Notre Dame Maritime Hospital, Jbeil, LBN.
Fida CharifVascular and Therapeutic Medicine, Centre Hospitalier Universitaire de Saint Etienne, Saint-Etienne, FRA.
Silvana El ZoghbiPediatric Pulmonology and Allergy, Notre Dame Maritime Hospital, Jbeil, LBN.
Samir ChallitaPulmonary and Critical Care, Notre Dame Maritime Hospital, Jbeil, LBN.
Fares ZaitounAllergy and Immunology, Rizk Hospital, Beirut, LBN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anaphylaxis, a potentially life-threatening systemic reaction, is an increasingly common reason for emergency department (ED) admissions, which often poses diagnostic challenges. We present a case of a 62-year-old man who had recurrent anaphylaxis, initially suspected to be triggered by non-steroidal anti-inflammatory drugs (NSAIDs). By conducting thorough history-taking and comprehensive allergy testing, we identified allergic sensitization to the omega-5-gliadin (O5G) component of gluten, which manifested only when wheat consumption was accompanied by specific factors, notably exercise or NSAID use. He was diagnosed eight years after the first anaphylactic episode with wheat-dependent exercise-induced anaphylaxis (WDEIA). Adherence to a gluten-free diet effectively prevented further episodes. This case underscores the importance of emergency physicians not only in treating anaphylaxis but also in recognizing rare diagnoses, such as cofactor-enhanced food-induced allergic reactions, and understanding their management. This awareness is critical not only for conducting comprehensive assessments in collaboration with allergy specialists but also for facilitating earlier diagnosis, educating patients about the use of epinephrine auto-injectors, and emphasizing essential avoidance measures to prevent the recurrence of anaphylaxis.

Indexed as

allergy and anaphylaxiscofactor-enhanced food allergy (cefa)food-dependent exercise-induced anaphylaxis (fdeia)omega-5 gliadin (ω-5 gliadin)wheat-dependent exercise-induced anaphylaxis (wdeia)

Identifiers

PMID40308419
PMCPMC12043355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.